UNSPSC 51281622: Ribostamycin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Q5JOU7T53. European Medicines Agency schedules Ribostamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10300MIG. Ribostamycin generally arises in the molecular formula C17H34N4O10.

UNSPSC 51281622 Ribostamycin, a Commodity code, addresses pharmaceutical procurement by state and local health agencies, though recent state and local opportunities tagged under this code do not involve ribostamycin specifically. The Illinois Department of Public Health and Seminole County, Florida have posted pharmaceutical acquisitions in the past few months—a warehouse piggyback through the MMCAP Infuse consortium for antimicrobial tablets (doxycycline and ciprofloxacin), and a competitive bid for naloxone and drug deactivation systems—indicating that state and local buyers use this code family to source injectable and oral pharmaceuticals, medical countermeasures, and emergency health supplies. Health departments and county public-health authorities are the primary issuing bodies under this code tier, typically purchasing through cooperative consortia, IFBs, or piggyback arrangements against established state or multi-state contracts.

The Illinois Department of Public Health awarded a $2,999,999.11 three-year pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse Chartwell Rx LLC contract vehicle, an Invitation for Bid that closed September 11, 2026. Seminole County, Florida solicited naloxone and drug deactivation systems through an IFB (Solicitation IFB60459723LAS) posted June 30, 2026, with a July 26 deadline, requiring 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. Both procurements reflect state and local emphasis on emergency medical supplies and public-health pharmaceuticals delivered through established supply chains or cooperative purchasing, with compliance requirements including E-Verify and drug-free workplace certification. Recent activity centers on Florida and Illinois; the code shows limited transparent activity nationally, suggesting either narrow use of this specific code tier or material tagging misalignment between actual procurement scope and UNSPSC classification.